Skip to content

Rocket Pharmaceuticals, Inc.

RCKT· NasdaqCore metricsCIK 1281895

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.83%
Market cap
$267.98M
111.66M shares
Filings
978
$0.00
Q3 2026
-$49.23M
Q3 2026N/M FY25 yoy
-$50.97M
Q3 2026N/M FY25 yoy
-$124.31M
Q3 2026derivedN/M FY25 yoy
-$0.43
Q3 2026N/M FY25 yoy
$95.47M
Q3 2026−52.6% FY25 yoy
$267.98M
—
—
0.8×
-59.42%
—

Twelve months to Sep 30, 2026 · derived

Price

$2.4026.61%$0.87past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$0.000FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20222022-12-31$0reported
FY 20212021-12-31$0reported
FY 20202020-12-31$0reported
FY 20192019-12-31$0reported
FY 20182018-12-31$0reported
FY 20172017-12-31$0reported
FY 20162016-12-31$0reported

Capital returns

Dividends and buybacks · FY2016 to FY2021
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2021—$0.00$0.00—64.51M sh+4.4%—
FY2020—$72.00K$72.00K—61.78M sh+12.2%—
FY2019—$0.00$0.00—55.07M sh+22.1%—
FY2018—$0.00$0.00—45.11M sh+14.5%—
FY2017—$0.00$0.00—39.40M sh+46.0%—

Pharmaceutical preparations

Rocket Pharmaceuticals, Inc. is the 231st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR